Fatal dengue virus infection in an unvaccinated traveler

Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals with documented prior infection. We present a fatal case of severe dengue in an unvaccinated traveler without known prior dengue virus infection but longitudinal serologic and molecular evidence for secondary infection. In the context of this case and vaccination guidance for travelers, we discuss pre-vaccination screening, potential implications for travelers to regions with ongoing outbreaks, and emphasize the importance of serostatus-independent vaccines.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Microbiology & Infectious Diseases
Published
2024-12-28
DOI
https://doi.org/10.1007/s10096-024-05021-4
Citations
1
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fatal dengue virus infection in an unvaccinated traveler

Jürgen Steinke, Henning Gruell, Veronica Di Cristanziano, Jan‐Hendrik Naendrup et al.
1 citations
European Journal of Clinical Microbiology & Infectious Diseases
Mosquito-borne diseases and control
0.54
article

Fatal dengue virus infection in an unvaccinated traveler

Jürgen Steinke, Henning Gruell, Veronica Di Cristanziano, Jan‐Hendrik Naendrup, Gertrud Steger, Dániel Cadar, Alexander Shimabukuro‐Vornhagen, Roger Grosser, Alexander Simonis, Rosanne Sprute, Jorge Garcia Borrega, Noëlle Sieg, Jonas Schmidt‐Chanasit, Lisa Altenrath, Martin Gabriel, Jesko Welters
article en
1 citations

Abstract

Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals with documented prior infection. We present a fatal case of severe dengue in an unvaccinated traveler without known prior dengue virus infection but longitudinal serologic and molecular evidence for secondary infection. In the context of this case and vaccination guidance for travelers, we discuss pre-vaccination screening, potential implications for travelers to regions with ongoing outbreaks, and emphasize the importance of serostatus-independent vaccines.

European Journal of Clinical Microbiology & Infectious DiseasesVol. 44(3)
Witten/Herdecke University (DE), Universität Hamburg (DE), University of Cologne (DE), Düsseldorf University Hospital (DE), Laboratory Dr. Wisplinghoff (DE), German Center for Infection Research (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE), Bernhard Nocht Institute for Tropical Medicine (DE)
Universitätsklinikum Köln
Good health and well-being
Openalex Percentile: Top 25%
Mosquito-borne diseases and control
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.